Price loading...

The 2025-2030 World Outlook for Anti-Rejection Drugs and Immunosuppressants for Liver Diseases Treatments

Price data last checked 91 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
Paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
04 April 2024

Similar Products You Might Like

The 2025-2030 World Outlook for Liver Disease Treatments
98% match

The 2025-2030 World Outlook for Liver Disease Treatments

Out of Stock 11 Mar 2026
The 2025-2030 World Outlook for Liver Cirrhosis Drugs
97% match

The 2025-2030 World Outlook for Liver Cirrhosis Drugs

Out of Stock 25 Jan 2026
The 2025-2030 World Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs
96% match

The 2025-2030 World Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs

Out of Stock 31 Jan 2026
The 2025-2030 World Outlook for Liver Cancer Therapeutics
95% match

The 2025-2030 World Outlook for Liver Cancer Therapeutics

Out of Stock 13 Jan 2026
The 2025-2030 World Outlook for Anti-Idiopathic Pulmonary Fibrosis Drugs
95% match

The 2025-2030 World Outlook for Anti-Idiopathic Pulmonary Fibrosis Drugs

Out of Stock 24 Jan 2026
The 2025-2030 World Outlook for Hepatitis C Drugs
95% match

The 2025-2030 World Outlook for Hepatitis C Drugs

Out of Stock 27 Jan 2026
The 2025-2030 World Outlook for Hepatitis C Treatments
95% match

The 2025-2030 World Outlook for Hepatitis C Treatments

Out of Stock 23 Jan 2026
The 2025-2030 World Outlook for Advanced Therapy Medicinal Products
95% match

The 2025-2030 World Outlook for Advanced Therapy Medicinal Products

Out of Stock 23 Jan 2026
The 2025-2030 World Outlook for Myeloproliferative Disorder Drugs
95% match

The 2025-2030 World Outlook for Myeloproliferative Disorder Drugs

Out of Stock 10 Dec 2025
The 2025-2030 World Outlook for Targeted Therapy Liver Cancer Drugs
95% match

The 2025-2030 World Outlook for Targeted Therapy Liver Cancer Drugs

£790.00 11 Jan 2026
The 2025-2030 World Outlook for Anti-Inflammatory Scleroderma Drugs
95% match

The 2025-2030 World Outlook for Anti-Inflammatory Scleroderma Drugs

Out of Stock 31 Jan 2026
The 2025-2030 World Outlook for Rare Disease Drugs
95% match

The 2025-2030 World Outlook for Rare Disease Drugs

Out of Stock 31 Jan 2026
The 2025-2030 World Outlook for Hepatitis C Therapies
95% match

The 2025-2030 World Outlook for Hepatitis C Therapies

Out of Stock 22 Jan 2026
The 2025-2030 World Outlook for Antiscalants-Scale Inhibitors
95% match

The 2025-2030 World Outlook for Antiscalants-Scale Inhibitors

Out of Stock 21 Jan 2026
The 2025-2030 World Outlook for Lou Gehrig's Disease Drugs
95% match

The 2025-2030 World Outlook for Lou Gehrig's Disease Drugs

Out of Stock 06 Feb 2026
The 2025-2030 World Outlook for Hepatitis C Therapeutics
95% match

The 2025-2030 World Outlook for Hepatitis C Therapeutics

Out of Stock 27 Jan 2026
The 2025-2030 World Outlook for Liver Organs-on-Chips
95% match

The 2025-2030 World Outlook for Liver Organs-on-Chips

Out of Stock 07 Feb 2026
The 2025-2030 World Outlook for Anti-Malarial Drugs
95% match

The 2025-2030 World Outlook for Anti-Malarial Drugs

Out of Stock 26 Jan 2026
The 2025-2030 World Outlook for Protein Drugs
95% match

The 2025-2030 World Outlook for Protein Drugs

Out of Stock 23 Jan 2026
The 2025-2030 World Outlook for Anticoagulant Drugs
95% match

The 2025-2030 World Outlook for Anticoagulant Drugs

Out of Stock 17 Dec 2025
The 2025-2030 World Outlook for Rare Disease Treatments
95% match

The 2025-2030 World Outlook for Rare Disease Treatments

Out of Stock 07 Feb 2026
The 2025-2030 World Outlook for Generic Antiviral Drugs
95% match

The 2025-2030 World Outlook for Generic Antiviral Drugs

Out of Stock 31 Jan 2026
The 2025-2030 World Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs
95% match

The 2025-2030 World Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs

£790.00 26 Jan 2026
The 2025-2030 World Outlook for Antibody Drug Conjugates
95% match

The 2025-2030 World Outlook for Antibody Drug Conjugates

Out of Stock 11 Jan 2026